# Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis

> **NCT04462003** · PHASE3 · UNKNOWN · sponsor: **Beni-Suef University** · enrollment: 100 (estimated)

## Conditions studied

- Deep Vein Thrombosis
- Malignancy

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Enoxaparin

## Key facts

- **NCT ID:** NCT04462003
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-07-03
- **Primary completion:** 2020-07-02
- **Final completion:** 2020-07-03
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04462003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04462003, "Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04462003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*